
Jan 21 (Reuters) - Johnson & Johnson JNJ.N:
J&J EXEC SAYS EXPECT TO ELEVATE FREE CASH FLOW GENERATION TO APPROXIMATELY $21 BILLION IN 2026 - CONF CALL
J&J EXEC SAYS FULL YEAR MEDTECH TARIFF IMPACT ANTICIPATED AT AROUND $500 MILLION WHICH IS SIGNIFICANTLY ABOVE THE 2025 AMOUNT
J&J EXEC SAYS DO NOT EXPECT LOSS OF ACA SUBSIDIES OR ANY POTENTIAL POLICY CHANGES UNDER THE ONE BIG BEAUTIFUL BILL TO HAVE MATERIAL IMPACT ON MEDTECH PERFORMANCE